finder Ireland

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mesoblast shares in Ireland | A$3.19

6 steps guide to buying and managing Mesoblast share in just a few minutes.

Soujanya Datta
Soujanya Datta

Posted

Fact checked
How you can invest Compare brokers
Picture not described

Mesoblast Limited is a biotechnology business based in Australia. Mesoblast shares (MSB) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Mesoblast employs 102 staff and has a trailing 12-month revenue of around AUDA$16.4 million.

How to buy shares in Mesoblast from Ireland

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Mesoblast Find the stock by name or ticker symbol: MSB. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Mesoblast reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of AUDA$3.19, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Mesoblast, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Mesoblast. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Compare online brokers to trade stocks, ETFs and CFDs

warning iconWarning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89 % of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Data indicated here is updated regularly
Name Product Number of Stocks CFDs Shares Available Markets Link
DEGIRO
DEGIRO
Access to global markets
No
Yes
AU, AT, BE, CA, CH, CZ, DE, DK, ES, FR, FI, GR, HK, HU, IT, JP, NO, PT, PL, IE, SG, SE, TR, UK, US
Go to site
More Info
Your capital is at risk.
eToro
eToro
2,000+
Yes
Yes
Worldwide with exception.
Go to site
71% of CFD accounts lose money
More Info
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Plus500
Plus500
2,000+
Yes
Yes
US, UK, AU, DE, FR, IT, PT, GR, JP, SG, ZA, NL, FI, BE, DK, SE, CH, ES, AT, NO, HU, CZ, IE, PL, HK
Go to site
76.4% of CFD accounts lose money
More Info
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
loading

Compare up to 4 providers

What's in this guide?

  1. Mesoblast shares summary
  2. Compare share dealing platforms
  3. Is Mesoblast stock a buy or sell?
  4. Mesoblast performance over time
  5. Mesoblast's financials
  6. How volatile are Mesoblast shares?
  7. Does Mesoblast pay a dividend?
  8. Other common questions

How has coronavirus impacted Mesoblast's share price?

Since the stock market crash in March caused by coronavirus, Mesoblast's share price has had significant positive movement.

Its last market close was AUDA$3.19, which is 13.79% up on its pre-crash value of AUDA$2.75 and 212.75% up on the lowest point reached during the March crash when the shares fell as low as AUDA$1.02.

If you had bought AUDA$1,000 worth of Mesoblast shares at the start of February 2020, those shares would have been worth AUDA$373.31 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth AUDA$1,077.71.

Mesoblast share price

Use our graph to track the performance of MSB stocks over time.

Mesoblast shares at a glance

Information last updated 2021-01-20.
Latest market closeAUDA$3.19
52-week rangeAUDA$1.02 - AUDA$5.7
50-day moving average AUDA$3.127
200-day moving average AUDA$3.7904
Wall St. target priceAUDA$2.87
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) AUDA$-0.182

Is it a good time to buy Mesoblast stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Mesoblast Limited by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mesoblast price performance over time

Historical closes compared with the last close of A$3.19

1 week (2021-01-15) 30.20%
1 month (2020-12-23) 34.60%
3 months (2020-10-23) 0.95%
6 months (2020-07-23) -9.89%
1 year (2020-01-23) 3.91%
2 years (2019-01-23) 132.00%
3 years (2018-01-23) 120.76%
5 years (2016-01-22) 109.25%

Mesoblast financials

Revenue TTM AUDA$16.4 million
Gross profit TTM AUDA$6.8 million
Return on assets TTM -9.82%
Return on equity TTM -19.14%
Profit margin 0%
Book value A$0.919
Market capitalisation AUDA$1.5 billion

TTM: trailing 12 months

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy Policy and Terms.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site